Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Naltrexone 50mg tablets
0410030E0AAAAAA
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 4,796 |
|
Naltrexone 4.5mg capsules
0410030E0AAAKAK
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 240 |
|
Naltrexone 3mg capsules
0410030E0AAAIAI
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 129 |
|
Naltrexone 5mg/5ml oral suspension
0410030E0AAATAT
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 59 |
|
Naltrexone 5mg/5ml oral solution
0410030E0AAAVAV
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 55 |
|
Naltrexone 2mg capsules
0410030E0AAAMAM
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 13 |
|
Naltrexone 1.5mg capsules
0410030E0AAANAN
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 3 |
|
Naltrexone 1.5mg/5ml oral solution
0410030E0AAAUAU
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 3 |
|
Naltrexone 12.5mg/5ml oral suspension
0410030E0AAACAC
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 1mg capsules
0410030E0AAAQAQ
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 1mg/5ml oral solution
0410030E0AAAJAJ
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 2.5mg capsules
0410030E0AAAEAE
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 25mg/5ml oral solution
0410030E0AAAWAW
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 25mg/5ml oral suspension
0410030E0AAAGAG
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 2mg/5ml oral solution
0410030E0AAADAD
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 3.5mg capsules
0410030E0AAAPAP
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
|
Naltrexone 3mg/5ml oral solution
0410030E0AAAHAH
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.